CANNES RETINA FESTIVAL
Sunday, September 10
Opening of continuing Film Projection
Symposium I: Anti-Angiogenesis (Part 1)
Presiding Officer: Susan B; Bressler Chair: Ursula Schmidt-Erfurth Moderator: Tom S. Chang
- Combined efficacy of intravitreal ranibizumab in two Phase III studies of CNV secondary to ARMD Anat Loewenstein
- Combined Safety of Intravitreal Ranibizumab in Two Phase III Studies of CNV Secondary to ARMD Paolo Lanzetta
- Two-year efficacy and safety results from the MARINA study Ursula Schmidt-Erfurth
- Consistency of effect of ranibizumab at 2 doses on contrast sensitivity in 3 Phase III and IIIB studies of patients with CNV secondary to AMD Jean-Francois Korobelnik
- Intravitreal Ranibizumab (LucentisTM) plus Verteporfin PDT for Neovascular ARMD: FOCUS 2-year Results Andrew Antoszyk
- PIER: Year 1 Results of a Phase IIIB Study of Ranibizumab Efficacy and Safety in CNV Due to ARMD Prema Abraham
- Pier: Year 1 FA/OCT Results in a study of Ranibizumab (Lucentis™) for CNV Due to ARMD William F. Mieler
- An OCT-Guided Variable-Dosing Regimen with Lucentis™ (Ranibizumab) in Neovascular AMD: One Year Results from the PrONTO Study Philip J. Rosenfeld
- Introduction of Featured Guest Lecture: Judah Folkman Presiding Officers: Didier Ducournau, Julia Haller and Gene de Juan
- Potential Future Advances in Ophthalmology from Research in Tumor Angiogenesis Judah Folkman, MD
Poster Session (AMD/ANTI-ANGIOGENESIS)
Symposium II: Anti-Angiogenesis (Part 2)
Presiding Officer: Lawrence Singerman Chair: David Williams Moderators: Frank Koch
- Open-label, multicenter, Phase II Study Assessing the safety and efficacy of same-day Verteporfin and liquid ranibizumab 0.5mg (PROTECT study) Sebastian Wolf
- Ranibizumab (Lucentis) Vision-Specific Quality of Life Trough 24 Months in Neovascular ARMD Subjects in Marina: A Phase III Clinical Trial Tom S. Chang
- Vision-Specific Quality of Life at 12 Months in Predominantly Classic Neovascular ARMD in Anchor: A Phase III Trial of Ranibizumab and Verteporfin PDT Neil M. Bressler
- The Value and Cost-Effectiveness of Interventions for Subfoveal Neovascular ARMD Melissa Brown
- Intravitreally Injected Anti-VEGF Drugs Exert a Biological Effect in the Fellow Eye Tongalp Tezel
- Pharmacokinetics of Intravitreal Bevacizumab (Avastin) Sophie J. Bakri
- Vitreous Levels of Unbound Bevacizumab and Unbound Vascular Endothelial Growth Factors in Two Human Subjects Paul M. Beer
- Stability of bevacizumab (Avastin) after withdrawal into a syringe and refrigeration or freezing Colin A. McCannel
- Intravitreal Bevacizumab for the treatment of CNV secondary to Ocular Histoplasmosis and Multifocal Choroiditis Sundeep Dev
- Short-Term Outcomes in over 500 Intravitreal Bevacizumab Treatments for Retinal or CVD at the New York Eye & Ear Infirmary Thomas O. Muldoon
- Intravitreal Bevacizumab As Isolated First Line Therapy In Patients With New Untreated CNV Membranes Alay Banker
- Six-month Follow up on 50 Consecutive Patients with Intravitreal Bevacizumab Injections for Neovascular ARMD Samira Khan
- Primary Intravitreal Bevacizumab (Avastin) for the Treatment of CNV secondary to ARMD: Results of the Pan-American Collaborative Retina Study Group Jans Fromow-Guerra
- Intravitreal Bevacizumab (Avastin) for the Treatment of Neovascular ARMD Alessandro Castellarin
- Intravitreal Bevacizumab (Avastin™) for Primary Treatment of Neovascular ARMD David F. Williams
- Intravitreal Bevacizumab (Avastin) Treatment of CNV Secondary to ARMD Richard F. Spaide
- Time to recurrence of ARMD-related CNV leakage after a single initial intravitreous injection bevacizumab (Avastin®): Implications for a retreatment Edgar L. Thomas
- A FA/ICG analysis of the retinal/choroidal vasculature and CNV membrane complex six months following intravitreal Avastin injections Paul E. Tornambe
- Intravitreal Bevacizumab Compared with PDT for Juxtafoveal CNV Membranes in ARMD Derek Barker
- Combination therapy for wet ARMD using verteporfin PDT and intravitreal bevacizumab Jose Dalma-Weiszhausz
- Combined PDT with Verteporfin and Intravitreal Bevacizumab for CNV in ARMD Gaurav K. Shah
- Combined PDT with Verteporfin and Intravitreal Bevacizumab for Subfoveal CNV in ARMD David Misch
- Combination Avastin and Reduced Fluence PDT for CNV David Callanan
- Intravitreal Bevacizumab (Avastin) enhanced Pegaptanib (Macugen) therapy for CNV in ARMD: An Avastin Booster Michael J. Tolentino
- Vitrectomy in Triple Therapy for CNV Frank H.J. Koch
Symposium III: Anti-Angiogenesis (Part 3)
Presiding Officer: Paul E. Tornambe Chair: Anthony Adamis Moderator: Albert Augustin
- C.L.E.A.R. – IT 1: A Phase I Safety, Tolerability, and Bioactivity Study of Intravitreal VEGFTrap in Patients with Neovascular ARMD Quan Dong Nguyen
- VEGF small interfering (si) RNA, for Treatment of Wet ARMD Lawrence J. Singerman
- The Effects of Combined Inhibition of PDGF-B and VEGF-A Signaling in Murine Models of Ocular Neovascularization Anthony Adamis
- The Role of a Selective VEGF Blockade in ARMD Thomas R. Friberg
- Anecortave Acetate Clinical Update Peter K. Kaiser
- Combined IVT with PDT for the treatment of CNV in ARMD Catherine Favard
- The effect of Kenalog as adjunctive treatment to Visudyne in minimally classic and occult neovascular ARMD: A prospective, randomized clinical trial Tom Sheidow
- Six-month Results of a Randomized, Double-Masked, Controlled Trial of IVT as an Adjunct to PDT in Predominantly Classic Neovascular ARMD. The Canadian RETINA Study David Maberley
- Large case series of different types of CNV after Combination Treatment (PDT with intravitreal Triamcinolone) Albert J. Augustin
- AMD-panel Moderator: Philip J. Rosenfeld
Monday, September 11
Opening of continuing Film Projection
Awards & Special Presentations Presiding Officers: Julia Haller, Gene de Juan, and George Williams
- Introduction of Pyron Award Winner Brooks W. McCuen, II
- Pyron Award Lecture: Evolving Concepts in Pharmacologic Vitreolysis Brooks W. McCuen, II
- Introduction of Founders Award Winner Kirk H. Packo
- Founders Award Lecture: Vitrectomy Technology – Where We’ve Been. Where We Are. Where We Are Going. Kirk H. Packo
- Pay for Performance: A True Quality Initiative or a Means of Cost Control William L. Rich, III
- American Retina Foundation Roy A. Levit
- Young Phisicians Section’s Crystal Apple Award Presentation
- PAT Survey Award
Poster Session (IMAGING/SURGICAL DEVICES & INSTRUMENTATION/PHARMACOLOGY/SOCIOECONOMICS)
Symposium IV: Imaging and AMD
Presiding Officer: Giovanni Staurenghi , Chair: Claude Boscher, Moderator: Gregg Kokame
- Retinal Measurements with 3D-OCT Alexander C. Walsh
- SOCT “Copernicus” a new diagnostic tool in retinology Jerzy Nawrocki
- Active CNV Without Subretinal or Intraretinal Fluid on OCT Imaging G. Baker Hubbard
- Dualing OCT Modalities: Contrasting Retinal Features Revealed by a Dual Mode High Speed Ultrahigh Resolution Spectral and Temporal OCT/SLO Imager Richard B. Rosen
- Spectral Domain OCT Provides New Insight Into the Extent of Macular Pathology in ARMD Cynthia A. Toth
- AMD, hypertension and potential cardiovascular risks with intravitreal Avastin injection Claude Boscher
- Humanistic Burden and Health Resource Utilization in Neovascular ARMD Patients from Five Countries Gisele Soubrane
- Comparison of Comorbid Conditions Between Wet ARMD Patients and a Control Cohort in the Medicare Population Gergana Zlateva
- Myocardial Infarction and Cerebrovascular Accident Rates in Patients with Neovascular ARMD in a Healthcare Claims Database Emily S. West
- Annual Rates of Cardiovascular Events in Medicare Neovascular ARMD Patients Tsontcho Ianchulev
- Long Term Results of the Age-Related Eye Disease Study Emily Y. Chew
- Vitamin Usage Patterns in the Prevention of Advanced ARMD in a Tertiary Care Population Susan B. Bressler
- Effect of Initial Visual Acuity on Visual Loss in Untreated ARMD Eyes with Subfoveal Neovascularization Lucian Del Priore
- Incident CNV Lesions in the Fellow Eyes of Participants with Unilateral Neovascular ARMD during the Submacular Surgery Trials Sharon D. Solomon
- Quantitative OCT Sub-Analysis in Neovascular ARMD SriniVas Sadda
- Treatment of Retinal Angiomatous Proliferation Lesions Associated with Pigment Epithelial Detachment with Focal Pulsed Laser Robert P. Murphy
- Results of a 1 Year Study of Feeder Vessel Therapy in ARMD Giovanni Staurenghi
- How many days after onset is it too late to evacuate submacular hemorrhage secondary to ARMD? Keye L. Wong
- Pneumatic displacement of submacular hemorrhage- a case series Wilson Heriot
- Comparison of Submacular Surgery and Natural History for the Treatment of Large Submacular Hemorrhages from MD John T. Thompson
- Recurrent CNV after Macular Translocation Surgery With 360-degree Peripheral Retinectomy Claxton A. Baer (Winner 2006 B&L Retina Fellows’ Forum Research Award)
- Subretinal Surgery for Peripapillary Subretinal Neovascular Membranes Gregg T. Kokame
- Prolonged Choroidal Hypofluorescence following Verteporfin PDT Combined with Intravitreal Triamcinolone Acetate Injection for Age-related CNVM Jeffrey K. Luttrull
- Increased Visual Acuity in Fellow Affected Eyes of Subjects Undergoing Therapy with Intravenous EVIZON™ (Squalamine lactate) for Exudative ARMD Michael Gast
- Two-year Phase II/III Results (IMT002) of a Visual Prosthesis for Treatment of Central Vision Loss due to End-Stage Macular Degeneration Henry L. Hudson
Symposium V: Surgical Devices and Instrumentation (Part 1)
Presiding Officer: Mike Trese, Chair: Tarek S. Hassan, Moderator: Claus Eckardt
- Evaluation of the Artificial Silicon Retina™ Device for the Treatment of Vision Loss from Retinitis Pigmentosa John S. Pollack
- Chronic retinal chip implant in blind patients with retinitis pigmentosa Gisbert Richard
- Results from a Chronically Implanted 16-Channel Epiretinal Prosthesis in Blind Subjects Robert J. Greenberg
- Shedding More Light on Endoillumination David R. Chow
- Initial Clinical Experience with a Patterned Scanning Laser (PASCAL) for the Treatment of Retinal Diseases Julia A. Haller
- Results of Ophthalmic Surgical Training Using a High-fidelity Surgical Simulator Coupled with a Curriculum Based on Task Breakdown and Analysis Michael Grodin
- Cannulation of the Suprachoroidal Space: Drug Delivery and Pharmacokinetics of Triamcinolone Acetonide and Bevacizumab Timothy W. Olsen
- Enzymatic Alteration of Vitreous Cavity Oxygen Levels Michael T. Trese
- 20 Gauge Sutureless Transconjunctival Vitrectomy Daniel Polya
- Transconjunctival 20-G Sutureless Vitrectomy Mikael Sebag
- 25 Gauge Vitrectomy: Outcomes and Complications Carl Regillo
- Complications of 25-gauge Vitrectomy Surgery Robert A. Mittra
- A Head-to-Head Intraoperative Clinical Comparison of Flow Rates: Electric vs. Pneumatic 25-gauge High-Speed Vitreous Cutters Tarek S. Hassan
- 23-Gauge Vitrectomy as an effective and safe alternative for sutureless vitreous surgery Keith A. Warren
- 23-Gauge Vitrectomy in 100 Eyes: Short-Term Visual Outcomes and Complications Harinderjit Singh
- Further experience with 23-gauge transconjunctival vitrectomy Claus Eckardt
- 23g Sutureless Vitrectomy: When and Why? Zoran Tomic
- A new 23 Gauge Vitrectomy System George A. Williams
- New Devices for Vitreoretinal Surgery Carl C. Awh
- Surgical Devices and Instrumentation Panel Discussion Moderator: Carl C. Awh
Tuesday, September 12
Opening of continuing Film Projection
Symposium VI: Surgical Devices and Instrumentation (Part 2)
Presiding Officer: Suber Huang, Chair: Steve Charles, Moderator: Oswaldo Brasil, Sr.
- Comparison Of Wound Leakage Between Straight And Tunnel Scleral Incisions After 25 Gauge Vitrectomy Luiz Hagemann
- The integrity of wound closure after 23 versus 25 gauge sutureless vitrectomy Oswaldo Moura Brasil, Jr.
- Unfavorable Surgical Events in 25 vs. 20 Gauge Vitreous Surgery Saad A. Shaikh
- Comparison of visual recovery time in patients undergoing 20g and 25 gauge vitreous surgery Suber S. Huang
- Vitreous Dynamics: The New Solid Development Concept. Vitreous Flow Analysis in 20, 23 and 25 Gauge Cutters Octaviano Magalhaes
- Fluid dynamics among different 25-gauge systems: principles for use in vitreoretinal surgery Michel E. Farah
- Improved understanding of TSV-25g Vitrectomy system: Qualitative High Speed Video Analysis Of Vitreous Movement Around Aperture of Vitreous Cutters Mark S. Humayun
- Interface Vitrectomy Steve T. Charles
- Passive Removal of Silicone Oil with 25-Gauge Transconjunctival Sutureless Vitrectomy Instruments Ziya Kapran
Symposium VII: Retinal Vascular Disease and Oncology
Presiding Officer: Suber Huang, Chair: Steve T. Charles, Moderator: Oswaldo Brasil, Sr.
- Reversal of Ischemic CRVO: A Novel Technique of Multiple Retinal Vein Decompression and Chorioretinal Venous Anastomosis Calvin A. Grant
- Radial optic neurotomy plus IVT with and without ILM peeling for CRVO Jose Garcia-Arumi
- Safety Profile of Various Steroids on Retinal Cells In Vitro Baruch D. Kuppermann
- Pegaptanib Sodium for the Treatment of ME Following CRVO John Wells
- Short Term Visual and Anatomic Outcomes Following Intravitreal Bevacizumab for ME Secondary to CRVO Jose A. Roca
- Intravitreal Bevacizumab For Treatment Of ME In Central And BRVO Ajay Dudani
- Ranibizumab (Lucentis) in ischemic CRVO: intermediate OCT and visual results from the RAVE trial Matthew S. Benz
- Retinoblastoma Tumor Vascular Heterogeneity: A Model for Angiogenic Vacular Maturation and Implications for Vascular Targeting Therapy Timothy G. Murray
- Standard and High Resolution Echographic Features of Melanocytoma Amy C. Schefler
Poster Session (DIABETIC RETINOPATHY/RETINAL VASCULAR DISEASE & ONCOLOGY/MACULAR SURGERY)
Symposium VIII: Diabetic Retinopathy (Part 1)
Presiding Officer: J. Fernando Arevalo, Chair: Athanasios Nikolakopoulus, Moderator: Robert L. Avery
- Clinical Detection of DME Using the Automated Retinal Imaging System Antonio P. Ciardella
- Factors Influencing Utilization of a Telemedicine Diabetic Retinopathy Assessment Program in the Primary Care Setting Ingrid E. Zimmer-Galler
- Diurnal Variation in Retinal Thickening Measured by OCT Michel J. Shami
- Subthreshold Micropulse Diode Laser Photocoagulation in the treatment of diabetic clinically significant ME Neelakshi Bhagat
- VEGF small interfering (si) RNA, Cand5, for Treatment of DME Jonathan L. Prenner
- Three-Year Results of a Multicenter Clinical Trial of the Fluocinolone Acetonide Intravitreal Implant to Treat DME Dean Eliott
- The I-vation Sustained Release Drug Delivery System and Intravitreal Implant Eugene de Juan, Jr.
- The Effect of the Oral PKC ? Inhibitor Ruboxistaurin on Visual Loss and DME Ronald P. Danis
- The Effect of an Epiretinal Membrane on IVT Treatment for DME Parin S. Gohel
- Predictive factors for visual outcome after IVT acetonide injection for DME Rishi Singh
- Pegaptanib Sodium in Diabetic Retinopathy: Improvements in DME, RNV, and Severity of Diabetic Retinopathy Victor Hugo Gonzalez
- OCT Following Pegaptanib Therapy in Diabetics: a Bioanatomic Study of DME David R. Guyer
- Intravitreal injection versus systemic Bevacizumab(Avastin) Therapy for DME Murat Oncel
- Interim Results of the R.E.A.D. Study: Ranibizumab for Edema of the Macula in Diabetes Diana V. Do
- Primary Intravitreal Bevacizumab (Avastin) for the Treatment of DME: Results of the Pan-American Collaborative Retina Study Group J. Fernando Arevalo
- Intravitreal Bevacizumab (Avastin) in the Treatment of PDR Robert L. Avery
- Injection of Intravitreal Avastin before Vitrectomy Surgery in the treatment of Severe PDR Stanislao Rizzo
- A Simple Predictor of Vitrase® Efficacy for BCVA Improvement in Patients with Diabetes and Severe Vitreous Hemorrhage Abdhish R. Bhavsar
- Vitrase for Vitreous Hemorrhage Revisited Michael A. Singer
- 25 Gauge Vitrectomy for Advanced PDR: A Consecutive Case Series Including Complex RD Firas M. Rahhal
- Diabetic traction detachment treated with bimanual 25g sutureless surgery (Is silicon oil necessary?) Athanasios Nikolakopoulos
- Reoperation After Diabetic Vitrectomy: Rate, Indications, Visual Outcomes, and Complications in an Urban Academic Medical Center Julie Gasperini
- Posterior Juxtascleral Injection of Triamcinolone Acetonide for Cases of Diabetic ME Unresponsive or Unamenable to Laser Treatment Franco M. Recchia
- Vitrectomy for DME: study design and preliminary results of VIDE Study, an Italian clinical trial Barbara Parolini
Symposium VIII: Diabetic Retinopathy (Part 2)
Panel Discussion Moderator: Harry W. Flynn Panelists: Tarek S. Hassan, Rodrigo Jorge, Frank HJ Koch, Brooks W. McCuen, II, Robert P. Murphy, Georgiy Stolyarenko
Symposium IX: Macular Surgery
Presiding Officer: Claudio Azzolini , Chair: Fabio Patelli , Moderator: Keye Wong
- Posterior RD and retinoschisis without a MH in highly myopic eyes: Clinical findings and management Hassan Mortada
- Myopic Traction Maculopathy: A Slowly Progressive and Treatable Disease Giacomo A. Panozzo
- 25 Gauge Macular Surgery: Results and Complications Fabio Patelli
- Surgical Treatment of Macular Pucker: Multicenter Clinical Trial Claudio Azzolini
- Outcomes of 25 gauge transconjonctival membrane peeling combined with sutureless phaco/IOL surgery Jean-Paul Berrod
- Combined Phacoemulsification and Vitrectomy for MH Repair Ioannis Theocharis
- Prospective randomized clinical trial comparing face down position and semi seated position after surgery for idiopathic full-thickness MH Alexandre Guillaubey
- ILM peeling prevents late reopening of closed MH Thierry C. Verstraeten
- 25 Gauge Transconjunctival Sutureless Vitrectomy for MH repair: how can we resolve technique-related problems? Federica Genovesi-Ebert
- Results of Surgical Management of Senile MH by 25-Gauge Trans-Conjunctival Sutureless Vitrectomy Compared to Standard Vitrectomy Systems C. Christopher Brown
- Idiopathic MH Following Pars Plana Vitrectomy For RD Francesco Boscia
Wednesday, September 13
Opening of continuing Film Projection
Symposium X: Retinal Detachment
Presiding Officer: Giampaolo Gini, Chair: Klaus Lucke, Moderator: Masoud Soheilian
- The Value and Cost-Effectiveness of Vitreoretinal Interventions Gary C. Brown
- Rhegmatogenous RD in myopic eyes after LASIK. Characteristics, surgical management and functional outcomes Anna Boixadera
- Use of 25-Gauge Pars Plana Vitrectomy Surgery for Primary Repair of Rhegmatogenous RD Amitabh Bharadwaj
- Visual and Anatomic Outcomes of Pneumatic Retinopexy Daniel B. Roth
- Results of Pneumatic Retinopexy in Phakic Eyes – A Prospective Comparison of the Clinical Trial Group Inclusion Criteria and Extended Criteria Stephen M. Conti
- Optic Pit RD – Attempt at a Unifying Theory Klaus Lucke
- Multiples Macular RD After successful Buckle Surgery: Infrared, Autofluorescence, oct and Microperimetric features Francesco Faraldi
- Incidence of RD after macular surgery: a retrospective study of 634 cases Catherine Creuzot
- Cataract Surgery and Vitrectomy for PVR: comparaisons Between Internal Tamponades and Lens Removal Techniques Marcio B. Nehemy
- Triamcinolone Acetonide in Silicone-filled Eyes as Adjunctive Treatment for PVR: A Randomized Clinical Trial Hamid Ahmadieh
- Effect of Intraoperative 5-Fluorouracil and Low Molecular Weight Heparin on the Outcome in High-Risk PVR Guruprasad S. Ayachit
- Primary Vitrectomy in the Treatment of RD in Highly Myopic Eyes with Axial Length Over 30mm Gregoire Minoyan
Symposium XI: Trauma
Presiding Officer: Giampaolo Gini, Chair: Klaus Lucke , Moderator: Masoud Soheilian
- Microbial Isolates and Sensitivities in Posterior-Segment Intraocular Foreign Body Injuries: A 10-year Review Samuel B. Barone
- Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis with and without Intraocular Antibiotic injection Masoud Soheilian
- Intraocular Foreign Body Removal at Walter Reed Army Medical Center During Operations Iraqi and Enduring Freedom Marcus Colyer
- Management of traumatic RD associated with open globe injuries Giampaolo Gini
Symposium XII: Pediatrics and Inflammatory Disease
Presiding Officer: Harry Flynn, Chair: Silvia Bopp, Moderator: Dan Martin
- Screening for retinopathy in the pediatric sickle cell patient population Harmeet Gill
- PFV: Clinical Spectrum and Therapeutic Approach Silvia Bopp
- Telemedicine Screening for Retinopathy of Prematurity: The Stanford Experience (SUNDROP) Steven R. Sanislo
- Safety and efficacy of intravitreal bevacizumab for retinopathy of prematurity Hugo Quiroz-Mercado
- Anti-VEGF Therapy for Pediatric Retinopathies: Which Case is the Right Case? Kimberly A. Drenser
- Endophthalmitis in the Newborn Kristen Hartley
- A 2006 Update on the Risks Associated with Intravitreous Injection and Guidelines for Safe Administration Emmett T. Cunningham
- Acute-onset Endophthalmitis Following Clear Corneal Cataract Surgery (1996-2005): Clinical Features, Microbiology and Visual Outcomes Geeta Lalwani
- Early Onset Endophthalmitis Caused by Aspergillus Species Following Cataract Surgery Harry W. Flynn, Jr.
- 25-Gauge Vitrectomy Management of Severe Post-Cataract Surgery Endophthalmitis Flavio A. Rezende
- Complete and Early Vitrectomy for Eyes with Postoperative Endophthalmitis Ferenc Kuhn
- In-office And Bedside Sutureless Vitrectomy for The Diagnosis Of Uveitis Robert G. Josephberg
- Three-Year Results of a Multi-Center Clinical Trial of Fluocinolone Acetonide Intravitreal Implants to Treat Posterior Uveitis Daniel F. Martin
Symposium XIII: Future Directions
Presiding Officer: Harry W. Flynn, Chair: Silvia Bopp, Moderator: Daniel F. Martin
- Sub-retinal injection of Bevacizumab (Avastin) in treating neovascular ARMD, 25 gauge approach Ehab El-Rayes
- Rationale for Genistein in the Prevention and Treatment of Diabetic Retinopathy Michael J. Cooney
- Application of Proteomic Analysis to Characterize the Molecular Pathways of the Vitreous and Retina in Health and Disease Bert M. Glaser
- Ultra-Wide Angle Fluorescein Angiographic Evaluation of the Retinal Periphery in the Management of Retinal Vascular Diseases Steven D. Schwartz
- New Pharmacologic Treatments for Retinal Disease: A Venture Capital Perspective Gilbert H. Kliman